AWARDS, GRANTS & PUBLICATIONS
- September 26, 2024 - Dr. Sindu Kanjeekal received a $30,000 WE-SPARK grant for her work on Establishing a biomarker discovery platform to track progression to treatment resistant neuroendocrine prostate cancer.
- September 26, 2024 - Dr. Rasna Gupta received a $30,000 WE-SPARK grant for her work on CDK4/6 inhibitors as immune modulators in HR+/HER2- breast cancer.
- September 26, 2024 - Dr. Nikesh Adunuri received a $5,000 WE-SPARK grant for his project on Effect of Incentive Spirometry on Length of Hospital Stay in Non-Critically Ill Patients Admitted to a General Medicine Unit
- September 19, 2024 - Anand Swaminath, MD1; Sameer Parpia, PhD2; Marcin Wierzbicki, PhD3; Vijayananda Kundapur, MD4; Sergio Faria, MD5; Gordon S. Okawara, MD1; Theodoros K. Tsakiridis, MD, PhD1; Naseer Ahmed, MD6; Alexis Bujold, MD7; Khalid Hirmiz, MD8; Timothy Owen, MD9; Nelson Leong, MD10; Kevin Ramchandar, MD11; Edith Filion, MD12; Harold Lau, MD13; Zsolt Gabos, MD14; Robert Thompson, MD15; Brian Yaremko, MD16; Selma Mehiri, MD, PhD17; Alexander V. Louie, MD, PhD18; Kimmen Quan, MD1; Mark N. Levine, CM, MD2; James R. Wright, MD, MSc1; Timothy J. Whelan, BM BCh1Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non–Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial. JAMA Oncol. Published online September 19, 2024. doi:10.1001/jamaoncol.2024.3089
- September 19, 2024 - Basmaji, John MD1; Arntfield, Robert MD1; Desai, Karishma MD1; Lau, Vincent I. MD, MSc2; Lewis, Kim MD, MSc3,4; Rochwerg, Bram MD, MSc3,4; Fiorini, Kyle MD1; Honarmand, Kimia MD, MSc5; Slessarev, Marat MD, PhD1; Leligdowicz, Aleks MD, PhD1; Park, Brian BSc1; Prager, Ross MD1; Wong, Michelle Y.S. MSc1; Jones, Philip M. MD, MSc6; Ball, Ian M. MD, MSc1; Orozco, Nicolas MD7,8; Meade, Maureen MD, MSc4; Thabane, Lehana PhD4; Guyatt, Gordon MD, PhD4. The Impact of Point-of-Care Ultrasound-Guided Resuscitation on Clinical Outcomes in Patients With Shock: A Systematic Review and Meta-Analysis. Critical Care Medicine (), September 18, 2024.
- September 4, 2024 - Ladak R, Fifield B, Porter L,, Hirmiz, K, Hamm, C (September 03, 2024) Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects. Cureus 16(9): e68576. doi:10.7759/cureus.68576
|